Ecolectro | $10,500,000 | (Nov 15, 2024)
Workflow | $3,000,000 | (Nov 15, 2024)
runQL | $1,600,000 | (Nov 15, 2024)
AristaMD
United States
- San Diego, California
- 15/11/2023
- Series C
- $16,500,000
AristaMD is focused on improving patient outcomes through more timely access to specialty care. Its eConsult solution platform provides a telehealth solution that empowers primary care providers with clinical workup checklists and the ability to conduct electronic consults (also known as eConsults or virtual consults) to significantly improve the patient referral process and allow greater access to timely, high-quality care. Designed to seamlessly integrate into physician referral workflows, the platform allows payers and providers to quickly and cost-effectively launch specialist eConsults using their own specialists or those provided by AristaMD’s board-certified panel of experts.
AristaMD’s platform has proven to deliver cost-effective, timely access to specialty care through eConsults, significantly reducing the need for face-to-face visits while increasing patient satisfaction. AristaMD partners with healthcare stakeholders to ensure their success in the transition to value-based care. For additional information, visit aristamd.com, or follow AristaMD Twitter https://twitter.com/Arista_MD.
- Industry Hospital & Health Care
- Website https://www.aristamd.com/
- LinkedIn https://www.linkedin.com/company/aristamd/about/
Related People
Brooke LeVasseurFounder
United States -
San Diego County, California
Brooke LeVasseur is the CEO of AristaMD and has 20 years of leadership experience launching new, innovative healthcare products and solutions to payers and providers, including software and eConsult solutions. Throughout her career, Brooke has worked with numerous startups in a variety of capacities, including corporate and commercial strategy, marketing and new business creation. She brings a wealth of experience drawing from executive roles at Thomson Reuters, Veracyte and Sequenom, as well as an array of consultant roles at industry-leading investment and healthcare companies such as Kleiner Perkins Caufield & Byers, Versant Ventures, Illumina, Cypher Genomics and GRAIL.
Brooke is an established entrepreneur and an innovative leader with experience identifying, developing and launching new business offerings while managing teams to achieve operational goals. She has expertise across the healthcare spectrum, from consumer health to devices and diagnostics. Brooke has forged deep industry relationships throughout the years and is known as a strong communicator with a track record of inspiring and aligning diverse stakeholder groups. She has led teams to successfully commercialize new, innovative healthcare tools and gain widespread clinician adoption and reimbursement. She holds a degree in English from Stanford University.
Corporate & Commercial Strategy • New Product Development • Competitive Intelligence • Business Development • Start-ups • Biotech • Forecasting • Market Research • Telehealth • Digital & Virtual Health • Value-based Care
ELICIT PLANT | $48,000,000 | (Nov 15, 2024)
Sunthetics | $4,000,000 | (Nov 15, 2024)
Vaulted Deep | $32,300,000 | (Nov 15, 2024)
Serenity | $5,500,000 | (Nov 15, 2024)
Airbound | $1,700,000 | (Nov 15, 2024)
Influur | $10,000,000 | (Nov 15, 2024)
Naturbeads | $9,890,632 | (Nov 15, 2024)
TestSprite | $1,500,000 | (Nov 15, 2024)
Impilo | $11,500,000 | (Nov 15, 2024)